Literature DB >> 8229080

Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index.

S W Coons1, P C Johnson.   

Abstract

The effects of regional heterogeneity on the accuracy of histological grading of gliomas are well known, but little has been reported about its implications for other diagnostic modalities. This study investigated the relationships of regional heterogeneity in tumor proliferative activity, measured by Ki-67 labeling indices (LI), and histological grades for 16 regionally sampled glioma resections. There was a strong correlation between histological grades and Ki-67 LI in individual regions (p < 0.001), and both methods demonstrated comparable heterogeneity. Heterogeneity increased with tumor grade, probably as an expression of the increased genetic instability that accompanies tumor progression. Similarly, regions with comparable proliferative activity tended to cluster, paralleling clonal expansion. Thus, both histological grading and Ki-67 LI are subject to heterogeneity-induced sampling errors that limit their diagnostic accuracy, particularly in small biopsies. However, fewer grading errors occurred when using both methods together than when using either method alone, suggesting that the use of multiple techniques may reduce the adverse effects of regional heterogeneity on diagnostic accuracy. Regional heterogeneity appears to be a ubiquitous feature of gliomas: it also has been reported in karyotype, p53 oncogene mutations, and PDGF and EGFR expression. The effects of regional heterogeneity on new methods for studying gliomas need to be considered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229080     DOI: 10.1097/00005072-199311000-00008

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  28 in total

1.  Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations.

Authors:  A Misra; P Chattopadhyay; A K Dinda; C Sarkar; A K Mahapatra; S E Hasnain; S Sinha
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Proliferation and motility responses of primary and recurrent gliomas related to changes in epidermal growth factor receptor expression.

Authors:  M E Berens; M D Rief; J R Shapiro; D Haskett; A Giese; A Joy; S W Coons
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

Review 3.  Fluorescence-guided surgery with aminolevulinic acid for low-grade gliomas.

Authors:  Benjamin K Hendricks; Nader Sanai; Walter Stummer
Journal:  J Neurooncol       Date:  2018-10-26       Impact factor: 4.130

4.  Prognostic factors in recurrent glioblastoma multiforme and anaplastic astrocytoma treated with selective intra-arterial chemotherapy.

Authors:  K L Chow; Y P Gobin; T Cloughesy; J W Sayre; J P Villablanca; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

5.  Lectin histochemistry of astrocytic tumors and in vitro characterization of lectin-induced modifications on the proliferation of the SW1088, U373 and U87 human astrocytic cell lines.

Authors:  I Camby; I Salmon; R De Decker; J L Pasteels; J Brotchi; A Danguy; R Kiss
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

6.  (99m)Tc-Tetrofosmin brain SPECT in the assessment of meningiomas-correlation with histological grade and proliferation index.

Authors:  Andreas D Fotopoulos; George A Alexiou; Ann Goussia; Athanasios Papadopoulos; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Spyridon Voulgaris; Spyridon Tsiouris
Journal:  J Neurooncol       Date:  2008-05-06       Impact factor: 4.130

7.  Good clinical course in infants with desmoplastic cerebral neuroepithelial tumor treated by surgery alone.

Authors:  Kazuhiko Sugiyama; Kazunori Arita; Takeshi Shima; Mitsuo Nakaoka; Takashi Matsuoka; Eiji Taniguchi; Tatsunori Okamura; Humiyuki Yamasaki; Yoshinori Kajiwara; Kaoru Kurisu
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

8.  Polyamine metabolism in gliomas.

Authors:  R I Ernestus; G Röhn; R Schröder; T Els; J Y Lee; N Klug; W Paschen
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

9.  Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma.

Authors:  Jonathon F Parkinson; Helen R Wheeler; Adele Clarkson; Catriona A McKenzie; Michael T Biggs; Nicholas S Little; Raymond J Cook; Marinella Messina; Bruce G Robinson; Kerrie L McDonald
Journal:  J Neurooncol       Date:  2007-11-15       Impact factor: 4.130

10.  Low-grade gliomas in older patients: a retrospective analysis of prognostic factors.

Authors:  Nader Pouratian; Melike Mut; Jay Jagannathan; M Beatriz Lopes; Mark E Shaffrey; David Schiff
Journal:  J Neurooncol       Date:  2008-08-06       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.